Skip to main content
SpringerLink
Log in

Immunosuppresive Therapy in Ocular Surface Transplantation

  • Chapter
Ocular Surface Disease Medical and Surgical Management

  • 766 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Holland EJ. Epithelial transplantation for the management of severe ocular surface disease. Trans Am Ophthalmol Soc 1996; 94:677–743.

    CAS  PubMed  Google Scholar 

  2. Niederkorn JY. Effect of cytokine-induced migration of Langerhans cells on corneal allograft survival. Eye 1995; 9(Pt 2):215–218.

    PubMed  Google Scholar 

  3. Shimazaki J, et al. Evidence of long-term survival of donor-derived cells after limbal allograft transplantation. Invest Ophthalmol Vis Sci 1999; 40:1664–1668.

    CAS  PubMed  Google Scholar 

  4. Tsubota K et al. Treatment of severe ocular-surface disorders with corneal epithelial stem-cell transplantation. N Engl J Med 1993; 340:1697–1703.

    Article  Google Scholar 

  5. Dua HS, Azuara-Blanco A. Allo-limbal transplantation in patients with limbal stem cell deficiency. Br J Ophthalmol 1999; 83:414–419.

    CAS  PubMed  Google Scholar 

  6. Xu KP, Wu Y, Zhou J, Zhang X. Survival of limbal stem cell allografts after administration of Cyclosporin A. Cornea 1999; 18:159–165.

    Google Scholar 

  7. Djalilian AR, Bagheri MM, Swanson PJ, Schwartz GS, Holland EJ. Keratolimbal allograft for the treatment of limbal stem cell deficiency. Oral Presentation, Castroviejo Cornea Society Annual Meeting, October 1999, Orlando, FL.

    Google Scholar 

  8. Rao SK, et al. Limbal allografting from related live donors for corneal surface reconstruction. Ophthalmology 1999; 106:822–828.

    Article  CAS  PubMed  Google Scholar 

  9. Tresesler PA, Foulks GN, Sanfilippo F. Expression of HLA antigens in the human cornea. Am J Ophthalmol 1984; 98: 763.

    Google Scholar 

  10. Salisbury JD, Gebhardt BM. Blood group antigens on human corneal cells demonstrated by immunoperoxidase staining. Am J Ophthalmol 1981; 91:46–50.

    CAS  PubMed  Google Scholar 

  11. Duke-Elder S, Ashton N. Action of cortisone on tissue reactions of inflammation and repair with special attention to the eye. Br J Ophthalmol 1951; 35:695.

    CAS  PubMed  Google Scholar 

  12. Djalilian AR, Sanderson J, Piracha AR, Holland EJ. The use of topical loteprednol etabonate (Lotemax) in cortico-steroid induced ocular hypertension following corneal transplantation. Oral Presentation, EBAA annual meeting, October 2000, Dallas, TX.

    Google Scholar 

  13. Reid IR. Glucocorticoid osteoporosis—mechanisms and management. Eur J Endocrinol 1997; 137:209–217.

    Article  CAS  PubMed  Google Scholar 

  14. Belin MW, Bouchard CS, Phillips TM. Update on topical cyclosporin A. Background, immunology, and pharmacology. Cornea 1990; 9:184–195.

    CAS  PubMed  Google Scholar 

  15. Holland EJ et al. Topical cyclosporin A in the treatment of anterior segment inflammatory disease. Cornea 1993;12: 413–419.

    CAS  PubMed  Google Scholar 

  16. Milani JK, et al. Prolongation of corneal allograft survival with liposome-encapsulated cyclosporine in the rat eye. Ophthalmology 1993; 100:890–896.

    CAS  PubMed  Google Scholar 

  17. Stevenson D, Tauber J, Reis BL. Efficacy and safety of cyclosporin A ophthalmic emulsion in the treatment of moderate-to-severe dry eye disease: a dose-ranging, randomized trial. The Cyclosporin A Phase 2 Study Group. Ophthalmology 2000; 107:967–974.

    Google Scholar 

  18. Keown P, Kahan BD, Johnston A, Levy G, Dunn SP, Cittero F, Grino JM, Hoyer PF, Wolf P, Halloran PF. Optimization of cyclosporine therapy with new therapeutic drug monitoring strategies: report from the International Neoral TDM Advisory Consensus Meeting (Vancouver, November 1997). Transplant Proc 1998; 30:1645–1649.

    Article  CAS  PubMed  Google Scholar 

  19. Hong JC, Kahan BD. Immunosuppressive agents in organ transplantation: past, present, and future. Semin Nephrol 2000; 20:108–125.

    CAS  PubMed  Google Scholar 

  20. Keown PA. New immunosuppressive strategies. Curr Opin Nephrol Hypertens 1998; 7:659–663.

    CAS  PubMed  Google Scholar 

  21. Gijtenbeek JM, van den Bent MJ, Vecht CJ. Cyclosporine neurotoxicity: a review. J Neurol 1999; 246:339–346.

    Article  CAS  PubMed  Google Scholar 

  22. Campana C, Regazzi MB, Buggia I, Molinaro M. Clinically significant drug interactions with cyclosporin. An update. Clin Pharmacokinet 1996; 30:141–179.

    Article  CAS  PubMed  Google Scholar 

  23. Kobayashi C, et al. Suppression of corneal graft rejection in rabbits by a new immunosuppressive agent, FK-506. Transplant Proc 1989; 21:3156–3158.

    CAS  PubMed  Google Scholar 

  24. Vanrenterghem YF. Which calcineurin inhibitor is preferred in renal transplantation: tacrolimus or cyclosporine? Curr Opin Nephrol Hypertens 1999; 8:669–674.

    Article  CAS  PubMed  Google Scholar 

  25. Cacciarelli TV, Green M, Jaffe R, et al. Management of posttransplant lymphoproliferative disease in pediatric liver transplant recipients receiving primary tacrolimus (FK506) therapy. Transplantation 1998; 66:1047–1052.

    Article  CAS  PubMed  Google Scholar 

  26. European Mycophenolate Mofetil Cooperative Study Group. Mycophenolate mofetil in renal transplantation: 3-year results from the placebo-controlled trial. Transplantation 1999; 68:391–396.

    Google Scholar 

  27. Larkin G, Lightman S. Mycophenolate mofetil. A useful immunosuppressive in inflammatory eye disease. Ophthalmology 1999; 106:370–374.

    Article  CAS  PubMed  Google Scholar 

  28. Reis A, Reinhard T, Voiculescu A et al. Mycophenolate mofetil versus cyclosporin A in high risk keratoplasty. Br J Ophthalmol 1999; 83:1268–1271.

    Article  CAS  PubMed  Google Scholar 

  29. MacDonald A, Scarola J, Burke JT, Zimmerman JJ. Clinical pharmacokinetics and therapeutic drug monitoring of sirolimus. Clin Ther 2000; 22 Suppl B:B101–121.

    Article  CAS  PubMed  Google Scholar 

  30. Kaplan B, Meier-Kriesche HU, Napoli KL, Kahan BD. The effects of relative timing of sirolimus and cyclosporine microemulsion formulation coadministration on the pharmacokinetics of each agent. Clin Pharmacol Ther 1998; 63:48–53.

    Article  CAS  PubMed  Google Scholar 

  31. Hoffman F, et al. Interleukin-2 receptor targeted therapy with monoclonal antibodies in the rate corneal graft. Cornea 1994; 13:440.

    Google Scholar 

  32. Ippoliti G, Fronterre A. Usefulness of CD3 or CD6 monoclonal antibodies in the treatment of acute corneal graft rejection. Transplant Proc 1989; 21:3133.

    CAS  PubMed  Google Scholar 

  33. Wiseman LR, Faulds D. Daclizumab: a review of its use in the prevention of acute rejection in renal transplant recipients. Drugs 1999; 58:1029–1042.

    Article  CAS  PubMed  Google Scholar 

  34. Yamagami S, et al. Suppression of corneal allograft rejection after penetrating keratoplasty by antibodies to ICAM-1 and LFA-1 in mice. Transplant Proc 1995; 27:1899.

    CAS  PubMed  Google Scholar 

  35. Gerber DA, Bonham CA, Thomson AW. Immunosuppressive agents: recent developments in molecular action and clinical application. Transplant Proc 1998; 30:1573–1579.

    Article  CAS  PubMed  Google Scholar 

Download references

Authors
  1. Ali R. Djalilian
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Robert B. Nussenblatt
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Edward J. Holland
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Springer-Verlag New York, Inc.

About this chapter

Cite this chapter

Djalilian, A.R., Nussenblatt, R.B., Holland, E.J. (2002). Immunosuppresive Therapy in Ocular Surface Transplantation. In: Ocular Surface Disease Medical and Surgical Management. Springer, New York, NY. https://doi.org/10.1007/0-387-21570-0_22

Download citation

  • DOI: https://doi.org/10.1007/0-387-21570-0_22

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-0-387-95161-4

  • Online ISBN: 978-0-387-21570-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation